THE RECENT CLINICAL TRIALS ON USE OF THE NOVEL DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A REVIEW

The recent clinical trials on use of the novel direct oral anticoagulants in patients with venous thromboembolism: a review

Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, requires an immediate anticoagulation, that has been carried out so far by administering a parenteral anticoagulant drug (heparin or derivatives) overlapped with an oral vitamin K antagonist (VKA), more often warfarin.Several new direct oral anticoagulants (DOAC

read more